Retour sur lavenir.net
   XIOR 27.500 € (+0,73 %)     KBC ANCORA 81.200 € (+2,53 %)     AEDIFICA 71.800 € (+0,35 %)     COLRUYT 33.080 € (-1,14 %)     GBL 82.150 € (+1,42 %)     KBC 114.850 € (+2,00 %)     ARGENX SE 699.200 € (-0,26 %)     UMICORE 26.080 € (-0,38 %)     CARE PROPERTY INV. 13.180 € (0,00 %)     ONWARD MEDICAL 2.875 € (+1,59 %)     AB INBEV 71.860 € (-0,06 %)     SOLVAY 26.180 € (+0,69 %)     SHURGARD 23.850 € (-0,21 %)     COFINIMMO 84.500 € (+0,54 %)     D'IETEREN GROUP 172.000 € (+2,69 %)     KINEPOLIS GROUP 29.650 € (+1,19 %)     VIOHALCO 19.700 € (+3,36 %)     AZELIS GROUP 10.240 € (-0,68 %)     UCB 243.900 € (+0,79 %)     VAN DE VELDE 30.500 € (-0,65 %)     TITAN S.A. 48.140 € (+0,59 %)     ACKERMANS V.HAAREN 280.100 € (+2,23 %)     TEXAF 44.000 € (+0,92 %)     WDP 22.260 € (+1,09 %)     CAMPINE 236.000 € (+2,16 %)     DEME GROUP 189.000 € (+1,07 %)     SYENSQO 67.200 € (+1,05 %)     PROXIMUS 6.850 € (-0,72 %)     MELEXIS 82.150 € (+0,86 %)     SOFINA 228.400 € (+2,06 %)     BEKAERT 41.650 € (+0,48 %)     LOTUS BAKERIES 10 940.000 € (+0,92 %)     MONTEA 68.300 € (+1,94 %)     AGEAS 68.450 € (+0,51 %)     ONTEX GROUP 2.680 € (+0,75 %)     BANQUP GROUP 2.240 € (-8,57 %)     IBA 15.600 € (+1,43 %)     SIPEF 95.300 € (+0,11 %)     CIE BOIS SAUVAGE 316.000 € (+0,96 %)     VASTNED 29.550 € (+0,17 %)     TUBIZE-FIN 211.600 € (+1,83 %)     INCLUSIO SA/NV 17.250 € (+5,18 %)     DECEUNINCK 2.080 € (+0,97 %)     ELIA GROUP 139.300 € (+1,24 %)     BPOST 1.802 € (+1,92 %)     RETAIL ESTATES 70.600 € (+0,86 %)     CMB.TECH 14.560 € (-0,14 %)     FAGRON 25.200 € (+0,80 %)     GIMV 49.850 € (+0,71 %)     BARCO 9.190 € (+0,49 %)     CENERGY 25.320 € (+5,41 %)     TESSENDERLO 21.350 € (-0,23 %)     WERELDHAVE BELGIUM 53.000 € (+1,53 %)     ASCENCIO 50.300 € (+0,70 %)     EVS BROADC.EQUIPM. 31.850 € (+2,25 %)     QUESTFOR GR-PRICAF 3.036 € (+1,18 %)     ATENOR 1.800 € (+0,28 %)     AGFA-GEVAERT 0.466 € (+1,20 %)     BREDERODE 102.200 € (+0,39 %)     FLUXYS BELGIUM D 19.900 € (+0,25 %)  
   LOUIS HACHETTE 1.613 € (+1,45 %)     ONCODESIGN PM 0.436 € (+2,11 %)     FDJ UNITED 23.120 € (+0,35 %)     VIRIDIEN 114.400 € (-0,69 %)     CVC CAPITAL 13.340 € (+2,30 %)     TONNER DRONES 0.040 € (+4,95 %)     NN GROUP 74.680 € (-1,53 %)     CSG 18.826 € (+0,19 %)     ADYEN 991.300 € (+3,49 %)     PROSUS 40.755 € (+4,34 %)     BAM GROEP KON 9.725 € (+6,28 %)     ARCELORMITTAL SA 58.280 € (+2,64 %)     ALFEN 18.600 € (+5,08 %)     APERAM 50.850 € (+2,36 %)     PHARMING GROUP 1.194 € (+6,75 %)     PHILIPS KON 23.800 € (+1,84 %)     ING GROEP N.V. 27.165 € (+2,76 %)     CM.COM 7.000 € (+1,74 %)     DSM FIRMENICH AG 71.760 € (+0,36 %)     SIGNIFY NV 20.640 € (+0,49 %)     WOLTERS KLUWER 61.720 € (-1,25 %)     ABN AMRO BANK N.V. 34.900 € (+2,83 %)     MAGNUM 13.848 € (-0,30 %)     HAVAS 16.700 € (+1,21 %)     ASML HOLDING 1 425.200 € (+1,15 %)     ARCADIS 34.740 € (-0,06 %)     AHOLD DEL 36.710 € (+0,16 %)     FASTNED 38.400 € (+4,21 %)     KPN KON 4.594 € (-0,58 %)     74SOFTWARE 39.000 € (+1,56 %)     THEON INTERNAT 31.600 € (-0,94 %)     VOPAK 47.380 € (+1,89 %)     BE SEMICONDUCTOR 279.900 € (+2,30 %)     UMG 20.550 € (+0,54 %)     IMCD 91.060 € (-0,18 %)     SHELL PLC 36.610 € (-1,35 %)     PLUXEE 11.900 € (+0,93 %)     WENDEL 90.350 € (+1,63 %)     SCOR SE 32.240 € (+1,07 %)     TOTALENERGIES 77.620 € (-1,31 %)     OVH 11.660 € (-0,68 %)     EUTELSAT COMMUNIC. 3.978 € (+4,79 %)     NEXITY 8.375 € (+2,95 %)     SANOFI 77.200 € (+0,42 %)     EURAZEO 46.780 € (+2,01 %)     METROPOLE TV 11.500 € (0,00 %)     DANONE 61.720 € (-0,23 %)     BUREAU VERITAS 27.110 € (+0,78 %)     THALES 231.800 € (+0,91 %)     LAGARDERE SA 17.800 € (+1,02 %)     SOCIETE GENERALE 71.670 € (+4,17 %)     MEDIANTECHNOLOGIES 5.630 € (+4,45 %)     CAPGEMINI 104.900 € (+1,75 %)     LECTRA 16.760 € (0,00 %)     EMEIS 15.100 € (+2,72 %)     CROSSJECT 2.335 € (+3,78 %)     ALTRI SGPS 5.280 € (+0,76 %)     LVMH 479.300 € (+1,42 %)     AEGON 7.582 € (+1,47 %)     BOLLORE 5.470 € (+1,77 %)  
News Réglementées
13/05/2026 08:22

EQS-Adhoc: Ottobock SE & Co. KGaA: Ottobock acquires patient care business from Blatchford in Norway for approximately € 110 million

EQS-Ad-hoc: Ottobock SE & Co. KGaA / Key word(s): Mergers and Acquisitions / Purchase of parts of a company
Ottobock SE & Co. KGaA: Ottobock acquires patient care business from Blatchford in Norway for approximately € 110 million

13-May-2026 / 08:22 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.


Disclosure of inside information in accordance with Article 17 of (EU) Regulation No. 596/2014:

Ottobock acquires patient care business from Blatchford in Norway for approximately € 110 million

Duderstadt, 13 May 2026

 

Ottobock SE & Co. KGaA SE & Co. KGaA (ISIN: DE000BCK2223) (Ottobock) today concluded a purchase agreement with Blatchford Ltd., UK, (Blatchford) to acquire Blatchford Norway A/S (Blatchford Norway) for a purchase price of approximately € 110 million.

The acquisition encompasses the Norwegian patient care business of Blatchford with eight locations and around 200 employees. The total revenue of Blatchford Norway most recently amounted to around € 40 million. Based on the existing profitability of the business as well as expected synergies, the acquisition will remain at the Ottobock’s Group profitability level.

By acquiring Blatchford Norway, Ottobock is further expanding its international Patient Care network, which includes more than 420 locations to date. Ottobock has not been represented with its own locations in the Norwegian market up to now. With this acquisition, the company strategically closes a gap in the European market and is consistently following its acquisition strategy of acquiring leading patient care companies and integrating them into its international network. This is being done in particular because close cooperation between operating doctors/hospitals, rehabilitation centres and O&P Patient Care clinics is becoming increasingly important due to technological developments in the orthosis & prosthesis (O&P) industry.

The transaction will be closed as planned within the next few days.

 

Investor contact:

Ottobock SE & Co. KGaA
Julia Hartmann
VP Investor Relations
Mobile +49 151 556 848 07
Julia.Hartmann@ottobock.de
 

 



End of Inside Information

13-May-2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language:English
Company:Ottobock SE & Co. KGaA
Max-Näder-Straße 15
37115 Duderstadt
Germany
Phone:+49 5527 848 - 0
E-mail:info@ottobock.com
Internet:https://corporate.ottobock.com
ISIN:DE000BCK2223
WKN:BCK222
Indices:SDAX
Listed:Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate BSX; Vienna Stock Exchange
EQS News ID:2326622

 
End of AnnouncementEQS News Service

2326622  13-May-2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière